Pinnacle Biologics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pinnacle Biologics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013947
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pinnacle Biologics Inc (Pinnacle Biologics), a subsidiary of Concordia Healthcare Corp. is a drug company that develops and markets photodynamic therapy products. The company offers products such as PHOTOFRIN PI, OPTIGUIDE PI, ETHYOL PI and DIOMED products. Its OPTIGUIDE PI products comprise light delivery system, coated silica laser fiber, proximal SMA-type laser connector, and distal light diffusing tips. The company offers its vital medicines used to treat various cancers and rare diseases. It sells products through a network of distributors in the US and abroad. Pinnacle Biologics is headquartered in Chicago, Illinois, the US.

Pinnacle Biologics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pinnacle Biologics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Pinnacle Biologics Acquires PHOTOFRIN And PHOTOBARR From Axcan Pharma 11
Venture Financing 13
Pinnacle Biologics Raises Funds Through Venture Financing 13
Pinnacle Biologics Secures US$1.5 Million In Venture Financing 14
Partnerships 15
Pinnacle Biologics Enters into Distribution Agreement with Orphan Canada for Photofrin 15
Pinnacle Biologics Enters Into Co-Marketing Agreement With Alkopharma 16
Licensing Agreements 17
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 17
Acquisition 18
Concordia Healthcare Acquires Pinnacle Biologics 18
Pinnacle Biologics Inc – Key Competitors 20
Pinnacle Biologics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pinnacle Biologics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pinnacle Biologics Inc, Medical Devices Deals, 2011 to YTD 2017 9
Pinnacle Biologics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Pinnacle Biologics Acquires PHOTOFRIN And PHOTOBARR From Axcan Pharma 11
Pinnacle Biologics Raises Funds Through Venture Financing 13
Pinnacle Biologics Secures US$1.5 Million In Venture Financing 14
Pinnacle Biologics Enters into Distribution Agreement with Orphan Canada for Photofrin 15
Pinnacle Biologics Enters Into Co-Marketing Agreement With Alkopharma 16
Pinnacle Oncology Enters Into Licensing Agreement With University Of Chicago For Radioprotector Technology 17
Concordia Healthcare Acquires Pinnacle Biologics 18
Pinnacle Biologics Inc, Key Competitors 20
Pinnacle Biologics Inc, Subsidiaries 21

★海外企業調査レポート[Pinnacle Biologics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GigaGen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary GigaGen Inc (GigaGen) is a pre-clinical biotherapeutics company that develops antibody therapies to treat diseases of immune dysregulation. The company discovers and develops monoclonal and polyclonal antibody therapies and T cell therapies derived from immune repertoires. Its single cell se …
  • BrainCool AB (BRAIN):企業の製品パイプライン分析2018
    Summary BrainCool AB (BrainCool), a subsidiary of Dignitana AB, is a medical device company that focuses on developing, and commercializing medical cooling systems for brain cooling and pain management. The company’s products are based on the principle that applying therapeutic hypothermia contribut …
  • Takara Bio Inc (4974):企業の財務・戦略的SWOT分析
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • MedImmune LLC:企業の戦略的SWOT分析
    MedImmune LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Caesars Entertainment Corporation:企業の戦略・SWOT・財務情報
    Caesars Entertainment Corporation - Strategy, SWOT and Corporate Finance Report Summary Caesars Entertainment Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Xiwang Special Steel Company Limited:企業の戦略・SWOT・財務情報
    Xiwang Special Steel Company Limited - Strategy, SWOT and Corporate Finance Report Summary Xiwang Special Steel Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Juvenile Diabetes Research Foundation-製薬・医療分野:企業M&A・提携分析
    Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type one diabetes. The organization conducts clinical trials for curing, preventing and treating for type one diabetes and its complications; and researching new drugs for patients to man …
  • PZ Cussons Nigeria Plc:企業の戦略・SWOT・財務分析
    PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report Summary PZ Cussons Nigeria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Regions Financial Corporation:戦略・SWOT・企業財務分析
    Regions Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Regions Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Illumina Inc (ILMN)-医療機器分野:企業M&A・提携分析
    Summary Illumina, Inc. (Illumina) provides genomic sequencing and array-based solutions for genetic analysis in the areas of molecular diagnostics, translational and consumer genomics, and oncology. The company’s portfolio encompasses sequencing tools and systems; sequencing kits and reagents; micro …
  • Air Mauritius Ltd.:企業の戦略・SWOT・財務情報
    Air Mauritius Ltd. - Strategy, SWOT and Corporate Finance Report Summary Air Mauritius Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • LGT Bank Ltd.:企業の戦略・SWOT・財務分析
    LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report Summary LGT Bank Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • MSM Malaysia Holdings Berhad (MSM):企業の財務・戦略的SWOT分析
    MSM Malaysia Holdings Berhad (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Greatship (India) Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Greatship (India) Ltd (GIL), a subsidiary of The Great Eastern Shipping Co. Ltd is an offshore oilfield service provider that offers shipping and transportation services. The company transports crude oil, petroleum products, gas and bulk commodities. It provides offshore logistics and drilli …
  • Wincanton Plc (WIN):企業の財務・戦略的SWOT分析
    Wincanton Plc (WIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • 3W Power S.A. (3W9K):企業の財務・戦略的SWOT分析
    3W Power S.A. (3W9K) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Crownhaitai Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Crownhaitai Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆